Patents by Inventor Andras Rab

Andras Rab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators, Pharmaceutical Compositions, and Uses Thereof
    Publication number: 20260041672
    Abstract: This disclosure relates to compounds that are cystic fibrosis transmembrane conductance regulator (CFTR) modulators and pharmaceutical compositions containing the same. In certain embodiments, this disclosure relates to methods of managing a CFTR related disease or condition or respiratory distress comprising administering an effective amount of a CFTR modulator disclosed herein to a subject in need thereof.
    Type: Application
    Filed: October 17, 2025
    Publication date: February 12, 2026
    Inventors: Eric Sorscher, Haian Fu, Huw Davies, Jeong Hong, Yuhong Du, Andras Rab, Candela Manfredi, Xun Yang, Zhi Ren
  • Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof
    Patent number: 12465595
    Abstract: This disclosure relates to compounds that are cystic fibrosis transmembrane conductance regulator (CFTR) modulators and pharmaceutical compositions containing the same. In certain embodiments, this disclosure relates to methods of managing a CFTR related disease or condition or respiratory distress comprising administering an effective amount of a CFTR modulator disclosed herein to a subject in need thereof.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: November 11, 2025
    Assignees: Emory University, Children's Healthcare of Atlanta, Inc.
    Inventors: Eric Sorscher, Haian Fu, Huw Davies, Jeong Hong, Yuhong Du, Andras Rab, Candela Manfredi, Xun Yang, Zhi Ren
  • Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators, Pharmaceutical Compositions, and Uses Thereof
    Publication number: 20230293498
    Abstract: This disclosure relates to compounds that are cystic fibrosis transmembrane conductance regulator (CFTR) modulators and pharmaceutical compositions containing the same. In certain embodiments, this disclosure relates to methods of managing a CFTR related disease or condition or respiratory distress comprising administering an effective amount of a CFTR modulator disclosed herein to a subject in need thereof.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 21, 2023
    Inventors: Eric Sorscher, Haian Fu, Huw Davies, Jeong Hong, Yuhong Du, Andras Rab, Candela Manfredi, Xun Yang, Zhi Ren